ConductScience.org, home

Paper41594182

Diagnostic Value of Serum and Salivary Podoplanin as Clinical Biomarkers for Distinguishing Oral Cancer from Oral Leukoplakia.

Uzun H and 8 others. Diagnostics (Basel), 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Diagnostic Value of Serum and Salivary Podoplanin as Clinical Biomarkers for Distinguishing Oral Cancer from Oral Leukoplakia. Papers, record 41594182. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41594182

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Diagnostic Value of Serum and Salivary Podoplanin as Clinical Biomarkers for Distinguishing Oral Cancer from Oral Leukoplakia.
PubMed
Journal
Diagnostics (Basel)
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-01-31
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Uzun HHafizehttps://orcid.org/0000-0002-1347-8498
2Bozarslan GGuvenhttps://orcid.org/0009-0009-1525-3813
3Dumur SSeyma
4Misirlioglu NFNaile Fevziyehttps://orcid.org/0009-0007-4735-4091
5Elgormus MNMehmet Nuri
6Duvarcı CCanan
7Gelisgen RRemise
8Karaaltin ABAysegul Batiogluhttps://orcid.org/0000-0002-8620-4375
9Yilmaz YZYetkin Zekihttps://orcid.org/0000-0002-5734-9751

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139314164Malignant transformation of oral leukoplakia: Systematic review and comprehensive meta-analysis.Oral Dis2025https://conductscience.org/library/papers/39314164PubMed
221225307Oral premalignant lesions: from a clinical perspective.Int J Clin Oncol2011https://conductscience.org/library/papers/21225307PubMed
322988448Podoplanin: emerging functions in development, the immune system, and cancer.Front Immunol2012https://conductscience.org/library/papers/22988448PubMed
439660339Serum Podoplanin Levels as a Potential Biomarker for Diabetic Nephropathy Progression: A Cross-Sectional Study.Diabetes Metab Syndr Obes2024https://conductscience.org/library/papers/39660339PubMed
518197849Management of potentially malignant disorders: evidence and critique.J Oral Pathol Med2008https://conductscience.org/library/papers/18197849PubMed
629496040Podoplanin emerges as a functionally relevant oral cancer biomarker and therapeutic target.Oral Oncol2018https://conductscience.org/library/papers/29496040PubMed
737536520Saliva biomarkers in oral disease.Clin Chim Acta2023https://conductscience.org/library/papers/37536520PubMed
839776043The Patterns of P53, E-Cadherin, β-Catenin, CXCR4 and Podoplanin Expression in Oral Squamous Cell Carcinoma Suggests a Hybrid Invasion Model: an Immunohistochemical Study on Tissue Microarrays.Head Neck Pathol2025https://conductscience.org/library/papers/39776043PubMed
922525603Expression of podoplanin and ABCG2 in oral erythroplakia correlate with oral cancer development.Oral Oncol2012https://conductscience.org/library/papers/22525603PubMed
1016804930Overexpression of podoplanin in oral cancer and its association with poor clinical outcome.Cancer2006https://conductscience.org/library/papers/16804930PubMed
1123473850Podoplanin expression in oral leukoplakia: tumorigenic role.Oral Oncol2013https://conductscience.org/library/papers/23473850PubMed
1235836514Diagnostic value of objective VELscope fluorescence methods in distinguishing oral cancer from oral potentially malignant disorders (OPMDs).Transl Cancer Res2022https://conductscience.org/library/papers/35836514PubMed
13280847Definition of leukoplakia and related lesions: an aid to studies on oral precancer.Oral Surg Oral Med Oral Pathol1978https://conductscience.org/library/papers/280847PubMed
1437093708Overexpression of Podoplanin Predicts Poor Prognosis in Patients With Glioma.Appl Immunohistochem Mol Morphol2023https://conductscience.org/library/papers/37093708PubMed
1532620265Minimally invasive procedures for the recognition and diagnosis of oral precancer and cancer.Dis Mon2020https://conductscience.org/library/papers/32620265PubMed
1635163233The Role of Podoplanin in Skin Diseases.Int J Mol Sci2022https://conductscience.org/library/papers/35163233PubMed
1733411001Oral tongue leukoplakia: analysis of clinicopathological characteristics, treatment outcomes, and factors related to recurrence and malignant transformation.Clin Oral Investig2021https://conductscience.org/library/papers/33411001PubMed
1833302498Oral Cancer and Precancer: A Narrative Review on the Relevance of Early Diagnosis.Int J Environ Res Public Health2020https://conductscience.org/library/papers/33302498PubMed
1931820851Prevalence and incidence of oral cancer in low- and middle-income countries: A scoping review.Eur J Cancer Care (Engl)2020https://conductscience.org/library/papers/31820851PubMed
2020371204Diagnostic clinical aids in oral cancer.Oral Oncol2010https://conductscience.org/library/papers/20371204PubMed

See all 35 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42828028Heterogeneous mechanisms, risk stratification, and translational advances in the malignant transformation of oral potentially malignant disorders to oral squamous cell carcinoma.Front Mol Biosci2026https://conductscience.org/library/papers/42828028

Source PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
PDPN10630PubTator's text mininghttps://conductscience.org/library/genes/10630

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41594182

GET https://conductscience.org/api/papers/v1/41594182/references?page=2